Radical Irradiation of T2 and T3 Bladder Carcinoma: A retrospective investigation

Authors

  • S. D. Fosså Department of Medical Oncology and Radiation Therapy, the Surgical Department, and the Department of Pathology, the Norwegian Radium Hospital, Oslo, Norway
  • S. Ous Department of Medical Oncology and Radiation Therapy, the Surgical Department, and the Department of Pathology, the Norwegian Radium Hospital, Oslo, Norway
  • O. S. Knudsen Department of Medical Oncology and Radiation Therapy, the Surgical Department, and the Department of Pathology, the Norwegian Radium Hospital, Oslo, Norway

DOI:

https://doi.org/10.3109/02841868509134423

Abstract

The relative 5-year survival was 32 per cent in 97 patients with T2 or T3 bladder carcinoma (1972–1978) treated with high dose radiation therapy (CRE ≥1700 reu). A slight but significant difference was noted between the two T categories. Fifty-three patients who were tumour-free 3 to 4 months after irradiation had a 55 per cent survival. No other prognostic parameters were identified on the basis of histologic or radiologic findings. In 14 patients severe radiation complications were observed (bladder 9, small bowel 3, combined 2). In patients with radiation sensitive bladder carcinoma, radical radiation therapy seems to be a comparable alternative to total cystectomy.

Downloads

Download data is not yet available.

Downloads

Published

1985-01-01

How to Cite

Fosså, S. D., Ous, S., & Knudsen, O. S. (1985). Radical Irradiation of T2 and T3 Bladder Carcinoma: A retrospective investigation. Acta Oncologica, 24(6), 497–501. https://doi.org/10.3109/02841868509134423